Nan Shan Life Insurance Co., Ltd. Eli Lilly & CO Transaction History

Nan Shan Life Insurance Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $33.5 Million - $39.3 Million	-120,174 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $1.42 Million - $1.76 Million	6,040 Added 5.29%	120,174 $34.4 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $12.2 Million - $15.1 Million	54,134 Added 90.22%	114,134 $31.5 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $7.22 Million - $9.34 Million	40,000 Added 200.0%	60,000 $13.8 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $3.29 Million - $4.25 Million	20,000 New	20,000 $3.74 Million

3,721

738M

7.09M

7.24M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $862B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Nan Shan Life Insurance Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Nan Shan Life Insurance Co., Ltd. with notifications on news.